Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease;Factores asociados a la falta de control de la hipertensión arterial en pacientes con y sin enfermedad cardiovascular

Revista Espanola de Cardiologia

Volumn 64, Issue 7, 2011, Pages 587-593

  Cordero, Alberto ^a   Bertomeu Martínez, Vicente ^a   Mazón, Pilar ^b   Fácila, Lorenzo ^c   Bertomeu González, Vicente ^a   Cosín, Juan ^d   Galve, Enrique ^e   Núñez, Julio ^f   Lekuona, Iñaki ^g   González Juanatey, José R ^b  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL PROVINCIAL DE CASTELLÓN   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Control; Hypertension; Lifestyle; Risk factors

Indexed keywords

ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CARDIAC PATIENT; CAROTID ARTERY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 79959380025     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.03.008     Document Type: Article

References (34)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart Disease and Stroke Statistics - 2011 Update: A Report From the American Heart Association Circulation 123 2011 e18 209
2. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
3. R. Gabriel, M. Alonso, A. Segura, M.J. Tormo, L.M. Artigao, and J.R. Banegas Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE Rev Esp Cardiol 61 2008 1030 1040
4. J.R. González-Juanatey, E. Alegría, J.V. Lozano, J.L. Llisteri, J.M. García, and I. González-Maqueda Impacto de la hipertensión en las cardiopatías en España. Estudio CARDIOTENS 1999 Rev Esp Cardiol 54 2001 139 149
5. D.L. Bhatt, P.G. Steg, E.M. Ohman, A.T. Hirsch, Y. Ikeda, and J.L. Mas International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189 (Pubitemid 43076437)
6. K. Kotseva, D. Wood, B.G. De, B.D. De, K. Pyorala, and U. Keil Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
7. V. Bertomeu, A. Cordero, J. Quiles, P. Mazón, J. Aznar, and H. Bueno Control de los factores de riesgo y tratamiento de la cardiopatía isquémica: Registro TRECE Rev Esp Cardiol 62 2009 807 811
8. P. Verdecchia, J.A. Staessen, F. Angeli, S.G. De, A. Achilli, and A. Ganau Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial Lancet 374 2009 525 533
9. P. Verdecchia, P. Sleight, G. Mancia, R. Fagard, B. Trimarco, and R.E. Schmieder Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease Circulation 120 2009 1380 1389
10. P. Sleight, J. Redon, P. Verdecchia, G. Mancia, P. Gao, and R. Fagard Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study J Hypertens 27 2009 1360 1369
11. H.C. Wijeysundera, M. Machado, F. Farahati, X. Wang, W. Witteman, and D.V. Van Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005 JAMA 303 2010 1841 1847
12. J.R. González-Juanatey, E. Alegría-Ezquerra, J. Aznar-Costa, V. Bertomeu-Martínez, J. Franch-Nadal, and J.L. Palma-Gamiz Conocimiento y aplicación de las guías de práctica clínica sobre riesgo cardiovascular en las consultas generales y especializadas Rev Esp Cardiol 59 2006 801 806 (Pubitemid 44540835)
13. O. Friedman, F.A. McAlister, L. Yun, N.R. Campbell, and K. Tu Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario Am J Med 123 2010 173 181
14. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187 (Pubitemid 46924065)
15. G. Mancia, S. Laurent, E. Gabiti-Rosei, E. Ambrosioni, M. Burnier, and M.J. Caulfield Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
17. L. Ryden, E. Standl, M. Bartnik, B.G. Van den, J. Betteridge, and M.J. De Boer Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136 (Pubitemid 46137814)
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:1-266.
19. A. Cordero, V. Bertomeu-Martínez, P. Mazón, J. Quiles, J. Aznar, and H. Bueno Differences in medical treatment of chronic coronary heart disease patients according to medical specialities Cardiovasc Ther 27 2009 173 180
20. F. Otero-Ravina, L. Grigorian-Shamagian, L. Fransi-Galiana, C. Nazara-Otero, J.M. Fernández-Villaverde, and A. Del Álamo-Alonso Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study Int J Cardiol 136 2009 56 63
21. D.L. Bhatt, K.A. Eagle, E.M. Ohman, A.T. Hirsch, S. Goto, and E.M. Mahoney Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis JAMA 304 2010 1350 1357
22. E. Falaschetti, M. Chaudhury, J. Mindell, and N. Poulter Continued improvement in hypertension management in England: results from the Health Survey for England 2006 Hypertension 53 2009 480 486
23. S. Dewilde, I.M. Carey, N. Richards, P.H. Whincup, and D.G. Cook Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment Heart 94 2008 83 88
24. D. Mozaffarian, P.W. Wilson, and W.B. Kannel Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease Circulation 117 2008 3031 3038
25. A. Cordero, M. León, E. Andrés, B. Ordoñez, M. Laclaustra, and A. Grima Gender differences in obesity related cardiovascular risk factors in Spain Prev Med 48 2009 134 139
26. S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, and P. Commerford Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study Lancet 366 2005 1640 1649 (Pubitemid 41552419)
27. A. Cordero, V. Bertomeu-Martínez, P. Mazón, D. Martín-Raymondi, J.L. Palma, and M. Anguita Short-term metabolic changes achieved by weight loss in hypertensive patients Int J Cardiol 2010 Sep 17 [Epub ahead of print]
28. W.Y. Craig, G.E. Palomaki, and J.E. Haddow Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data BMJ 298 1989 784 788 (Pubitemid 19084522)
29. E. Kvaavik, H.E. Meyer, and A. Tverdal Food habits, physical activity and body mass index in relation to smoking status in 40-42 year old Norwegian women and men Prev Med 38 2004 1 5 (Pubitemid 37524047)
30. B. Aggarwal, and L. Mosca Lifestyle and psychosocial risk factors predict non-adherence to medication Ann Behav Med 40 2010 228 233
31. V. Bertomeu, L. Fácila, J.R. González-Juanatey, L. Cea-Calvo, J. Aznar, and P. Mazón Control de las cifras de presión arterial en los pacientes hipertensos con hipertrofia ventricular: estudio VIIDA Rev Esp Cardiol 60 2007 1257 1263 (Pubitemid 350294325)
32. J. Redón, L. Cea-Calvo, B. Moreno, S. Monereo, V. Gil-Guillén, and J.V. Lozano Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly J Hypertens 26 2008 1757 1764
33. D. Orozco-Beltrán, C. Brotons, I. Moral, N. Soriano, M.A. Del Valle, and A.I. Rodríguez Determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular (estudio PREseAP) Rev Esp Cardiol 61 2008 317 321
34. S.R. Preis, S.J. Hwang, S. Coady, M.J. Pencina, R.B. D'Agostino, and P.J. Savage Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 Circulation 119 2009 1728 1735